Source:http://linkedlifedata.com/resource/pubmed/id/21784979
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
32
|
pubmed:dateCreated |
2011-8-11
|
pubmed:abstractText |
Although our understanding of the molecular regulation of adult neovascularization has advanced tremendously, vascular-targeted therapies for tissue ischemia remain suboptimal. The master regulatory transcription factors of the hypoxia-inducible factor (HIF) family are attractive therapeutic targets because they coordinately up-regulate multiple genes controlling neovascularization. Here, we used an inducible model of epithelial HIF-1 activation, the TetON-HIF-1 mouse, to test the requirement for VEGF in HIF-1 mediated neovascularization. TetON-HIF-1, K14-Cre, and VEGF(flox/flox) alleles were combined to create TetON-HIF-1:VEGF(?) mice to activate HIF-1 and its target genes in adult basal keratinocytes in the absence of concomitant VEGF. HIF-1 induction failed to produce neovascularization in TetON-HIF-1:VEGF(?) mice despite robust up-regulation of multiple proangiogenic HIF targets, including PlGF, adrenomedullin, angiogenin, and PAI-1. In contrast, endothelial sprouting was preserved, enhanced, and more persistent, consistent with marked reduction in Dll4-Notch-1 signaling. Optical-resolution photoacoustic microscopy, which provides noninvasive, label-free, high resolution, and wide-field vascular imaging, revealed the absence of both capillary expansion and arteriovenous remodeling in serially imaged individual TetON-HIF-1:VEGF(?) mice. Impaired TetON-HIF-1:VEGF(?) neovascularization could be partially rescued by 12-O-tetradecanoylphorbol-13-acetate skin treatment. These data suggest that therapeutic angiogenesis for ischemic cardiovascular disease may require treatment with both HIF-1 and VEGF.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/R01 EB000712,
http://linkedlifedata.com/resource/pubmed/grant/R01 EB008085,
http://linkedlifedata.com/resource/pubmed/grant/R01 NS46214,
http://linkedlifedata.com/resource/pubmed/grant/R01-CA90722,
http://linkedlifedata.com/resource/pubmed/grant/U54 CA136398
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cre recombinase,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoxia-Inducible Factor 1, alpha...,
http://linkedlifedata.com/resource/pubmed/chemical/Integrases,
http://linkedlifedata.com/resource/pubmed/chemical/Tetracycline,
http://linkedlifedata.com/resource/pubmed/chemical/Tetradecanoylphorbol Acetate,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1091-6490
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
9
|
pubmed:volume |
108
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
13264-9
|
pubmed:meshHeading |
pubmed-meshheading:21784979-Animals,
pubmed-meshheading:21784979-Cell Proliferation,
pubmed-meshheading:21784979-Endothelial Cells,
pubmed-meshheading:21784979-Epithelial Cells,
pubmed-meshheading:21784979-Gene Deletion,
pubmed-meshheading:21784979-Hypoxia-Inducible Factor 1, alpha Subunit,
pubmed-meshheading:21784979-Integrases,
pubmed-meshheading:21784979-Keratinocytes,
pubmed-meshheading:21784979-Mice,
pubmed-meshheading:21784979-Microvessels,
pubmed-meshheading:21784979-Myeloid Cells,
pubmed-meshheading:21784979-Neovascularization, Pathologic,
pubmed-meshheading:21784979-Tetracycline,
pubmed-meshheading:21784979-Tetradecanoylphorbol Acetate,
pubmed-meshheading:21784979-Vascular Endothelial Growth Factor A
|
pubmed:year |
2011
|
pubmed:articleTitle |
VEGF is essential for hypoxia-inducible factor-mediated neovascularization but dispensable for endothelial sprouting.
|
pubmed:affiliation |
Urology Division, Department of Surgery, and Department of Medicine, University of Hawaii 96813, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|